Retraction Note: Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia
Di Cui, Xilong Cui, Xiaoliang Xu, Wenjing Zhang, Yu Yu, Yingxin Gao, Chuanzhong Mei, Weiwei Zheng · 2026
Read Retraction Note: Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia by Di Cui, Xilong Cui, Xiaoliang Xu, Wenjing Zhang, Yu Yu, Yingxin Gao, Chuanzhong Mei, Weiwei Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13539929.txt.
Description
A retraction note for a 2022 BMC Cancer paper that named the protein TLN1 as a prognostic marker in acute myeloid leukemia. The editors retracted it after readers flagged similarities between two panels of Figure 7C. The ethics approval papers the authors supplied also could not be validated by the publisher. The authors' replies resolved neither concern. The editors say they have lost confidence in the article and in how the study was run. One listed author, Weiwei Zhang, disagrees with the retraction. Seven others never responded to the publisher.
Catalog record
| CREATOR | Di Cui, Xilong Cui, Xiaoliang Xu, Wenjing Zhang, Yu Yu, Yingxin Gao, Chuanzhong Mei, Weiwei Zheng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |